Outcomes of initially expectantly managed patients with low- or intermediate-risk screen-detected localized prostate cancer

被引：0
|
作者：
Bul, M. [1 ]
Van den Bergh, R. C. N. [1 ]
Zhu, X. [1 ]
Bangma, C. H. [1 ]
Schroder, F. H. [1 ]
Roobol, M. J. [1 ]
机构：
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1086 / U263
页数：2
相关论文
共 50 条
  • [21] CAUSES OF DEATH IN PATIENTS WITH SCREEN-DETECTED PROSTATE CANCER
    Poehl, Kimberly A.
    Suarez, Brian K.
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 292 - 292
  • [22] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [23] Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer
    Dixon, Christopher M.
    Levin, Richard M.
    Cantrill, Christopher H.
    Regelman, Mikhail
    Spilseth, Benjamin
    Tutrone, Ronald F. F.
    White, Michael A.
    Milbank, Aaron J.
    Warlick, Christopher A.
    [J]. JOURNAL OF ENDOUROLOGY, 2023, 37 (02) : 225 - 232
  • [24] Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB
    Chua, Samantha
    Qureshi, Muhammad M.
    Boyd, Graham
    Gignac, Gretchen A.
    Hirsch, Ariel E.
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : E531 - E542
  • [25] Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review
    Rodrigues, George
    Yao, Xiaomei
    Loblaw, D. Andrew
    Brundage, Michael
    Chin, Joseph L.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12): : 463 - 470
  • [26] Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease
    Walser, Eric
    Nance, Anne
    Ynalvez, Leslie
    Yong, Shan
    Aoughsten, Jacqueline S.
    Eyzaguirre, Eduardo J.
    Williams, Stephen B.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (03) : 401 - 409
  • [27] 15-year outcomes following conservative management among patients with screen-detected localized prostate cancer.
    Lu-Yao, Grace L.
    Albertsen, Peter C.
    Moore, Dirk
    Lin, Yong
    DiPaola, Robert S.
    Yao, Siu-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance
    Whalen, Michael J.
    Pak, Jamie S.
    Lascano, Danny
    Ahlborn, David
    Matulay, Justin T.
    McKiernan, James M.
    Benson, Mitchell C.
    Wenske, Sven
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E425 - E435
  • [29] Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
    Courtney, P. Travis
    Deka, Rishi
    Kotha, Nikhil, V
    Cherry, Daniel R.
    Salans, Mia A.
    Nelson, Tyler J.
    Kumar, Abhishek
    Luterstein, Elaine
    Yip, Anthony T.
    Nalawade, Vinit
    Parsons, J. Kellogg
    Kader, A. Karim
    Stewart, Tyler F.
    Rose, Brent S.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 151 - +
  • [30] SBRT in low- and intermediate-risk prostate cancer: results of a phase II study
    D'Agostino, G.
    Villa, E.
    Franzese, C.
    Liardo, R.
    Reggiori, G.
    Navarria, P.
    Iftode, C.
    De Rose, F.
    Franceschini, D.
    Tozzi, A.
    Comito, T.
    Ascolese, A.
    Tomatis, S.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S628 - S629
12345